Enwei Pharmaceutical Co., Ltd. (SHE:301331)
26.36
-0.65 (-2.41%)
At close: Mar 20, 2026
4.44% (1Y)
| Market Cap | 2.66B +8.3% |
| Revenue (ttm) | 888.64M +14.6% |
| Net Income | 52.06M +47.1% |
| EPS | 0.52 +49.9% |
| Shares Out | 101.08M |
| PE Ratio | 50.58 |
| Forward PE | n/a |
| Dividend | 0.35 (1.30%) |
| Ex-Dividend Date | Jan 8, 2026 |
| Volume | 969,590 |
| Average Volume | 1,136,274 |
| Open | 27.01 |
| Previous Close | 27.01 |
| Day's Range | 26.28 - 27.41 |
| 52-Week Range | 21.64 - 39.66 |
| Beta | 0.62 |
| RSI | 40.67 |
| Earnings Date | Apr 27, 2026 |